Active ingredients in WP, such as oxidized glutathione, may improve symptoms of HFD-induced obesity by acting on targets such as EGFR, NOS3, MMP2, PLG, PTGS2, and AR. This evidence concerns the gene AR and obesity due to melanocortin 4 receptor deficiency.